Picture of SANUWAVE Health logo

SNWV — SANUWAVE Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

SANUWAVE Health Q1 swings to operating loss as margins fall

Overview

US wound care products provider's Q1 revenue rose 3.1% yr/yr to record Q1 level

Company posted operating loss of $1.1 mln, compared to operating income last year

Gross margin fell to 77.3% from 79.0% due to lower pricing for reseller sales

Outlook

Company forecasts Q2 2026 revenue of $11.1-$11.6 mln, up 10-15% from Q2 2025

SANUWAVE reiterates full-year 2026 revenue guidance of $51.0-$55.0 mln, up 16-25% from 2025

Company expects 2026 to show continued improvement as market conditions recover

Result Drivers

CONSUMABLES GROWTH - Ultramist consumables revenue rose 15% yr/yr, driven by both new placements and increased activity at existing users

LOWER PRICING - Gross margin decline attributed to more sales through resellers at wholesale pricing

SLOW START TO QUARTER - Company said January was particularly weak due to market disruption from reimbursement changes, with improvement seen in later months

Company press release: ID:nGNX9mhb1

Key Details

MetricBeat/MissActualConsensus Estimate
Q1 Revenue$9.60 mln$9.63 mln (2 Analysts)
Q1 Net Income-$1.40 mln
Q1 Gross Margin77.30%
Q1 Operating Income-$1.10 mln
*Applies to a deviation of less than 1%; not applicable for per-share numbers. Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell" Wall Street's median 12-month price target for SANUWAVE Health Inc is $43.50, about 171.9% above its May 11 closing price of $16.00 The stock recently traded at 28 times the next 12-month earnings vs. a P/E of 29 three months ago For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on SANUWAVE Health

See all news